I now have comprehensive data for all 5 OSCE stations. Let me compile the complete study guide.Here is your complete OSCE study guide for Endometriosis, covering all 5 stations:
🩺 OSCE EXAM PREP: ENDOMETRIOSIS — Complete 5-Station Guide
STATION 1 — HISTORY TAKING
Opening
Introduce yourself, confirm patient identity, establish rapport. Ask open-ended question first: "Can you tell me what brings you in today?"
Core Symptom Complex (SOCRATES for each)
| Symptom | Key Details to Elicit |
|---|
| Dysmenorrhea | Onset (primary vs. secondary — started after pain-free periods?), severity (VAS 0–10), timing (begins 1–2 weeks before menses, continues through period), character (crampy, sharp, pressure-like) |
| Pelvic pain | Cyclic vs. chronic, distribution (midline, lower abdomen, back, rectal), radiation |
| Dyspareunia | Deep thrust (posterior cul-de-sac/uterosacral involvement), timing |
| Dyschezia | Painful defecation, especially cyclically with menses (rectovaginal/bowel involvement) |
| Urinary symptoms | Cyclic urgency, frequency, haematuria (bladder endometriosis) |
| Abnormal bleeding | Irregular bleeding despite ovulatory cycles |
| Infertility | Duration of trying to conceive, previous pregnancies |
Extra-pelvic Symptoms (ask if cyclic)
- Chest pain, haemoptysis, pneumothorax symptoms → thoracic endometriosis
- Cyclically painful scar/mass on abdomen → abdominal wall endometriosis
Gynaecological History
- Menarche age (early menarche = risk factor)
- Cycle regularity, length, duration, heaviness
- Contraceptive use (has OCP been tried? — partial relief suggests endometriosis)
- Previous gynaecological surgery
Obstetric History
- Nulliparity is a risk factor
- Mullerian anomalies (outflow obstruction)
Past Medical / Surgical History
- Prior laparoscopy findings?
- Previous diagnoses: adenomyosis, fibroids, IBS, IC/PBS (common co-morbidities)
Family History
- First-degree relative with endometriosis (genetic predisposition)
Social History
- Impact on quality of life, work/school absenteeism
- Relationship impact (dyspareunia)
Red Flags to Screen
- Weight loss, night sweats, bowel habit change (exclude IBD, malignancy)
- Age of onset, duration of symptoms (average delay in diagnosis = 7–10 years)
Exam Marking Tip
Examiners look for: the "endometriosis triad" — dysmenorrhea + dyspareunia + dyschezia and asking about infertility and cyclic nature of non-gynae symptoms.
STATION 2 — PATIENT EDUCATION
Explain in Simple Language
"What is endometriosis?"
"Endometriosis is a condition where tissue similar to the lining of your womb grows in places outside the womb — for example, on the ovaries, fallopian tubes, bowel, or bladder. Like the normal womb lining, this tissue responds to your menstrual hormones each cycle — it swells and bleeds but has nowhere to go, causing inflammation, scarring, and pain."
Key points to cover:
-
Prevalence: Affects approximately 1 in 10 women of reproductive age. It is NOT rare.
-
It is NOT your fault: Not caused by anything you did. Not contagious. Not a form of cancer (though rare malignant transformation can occur with long-standing endometriomas).
-
Symptoms vary: Some women have severe pain; others with extensive disease have none. Pain severity does NOT reflect disease severity.
-
Common sites: Ovaries (endometriomas/"chocolate cysts"), uterosacral ligaments, cul-de-sac (pouch of Douglas), bowel, bladder.
-
Impact on fertility: Endometriosis can affect your ability to fall pregnant naturally. This does not mean you cannot have children — many women with endometriosis conceive, with or without treatment.
-
Chronic condition: Endometriosis tends to return after treatment, especially before menopause. Management is long-term.
-
Treatment options (age-appropriate counselling):
- Pain medicines (NSAIDs) for symptom relief
- Hormonal treatments (pill, progestins, injections, IUS) to suppress the tissue
- Surgery (laparoscopy) to remove lesions — especially for fertility or diagnostic purposes
- Assisted reproduction (IVF) if natural conception is not achieved
-
Follow-up: Regular gynaecology reviews needed. Symptoms returning or new symptoms should prompt reassessment.
-
Lifestyle: Exercise, physiotherapy and psychological support can improve quality of life. Discuss support groups (e.g., Endometriosis UK/Foundation).
STATION 3 — DIAGNOSIS
Clinical Diagnosis (Non-Surgical)
History alone is suggestive — particularly:
- Secondary dysmenorrhea (pain-free cycles then onset of dysmenorrhea)
- Deep dyspareunia
- Cyclic dyschezia
- History of infertility
Physical Examination findings:
- Bimanual/rectovaginal exam: uterosacral nodularity, focal tenderness
- Fixed, retroverted uterus or laterally deviated cervix (fibrosis from endometriosis)
- Adnexal mass (endometrioma)
- Localised tenderness in broad ligament / uterosacral area
- Cyclically painful abdominal wall mass → scar endometriosis
Clinical (non-surgical) diagnosis is accurate in approximately 50% of cases
Investigations
| Investigation | Finding / Significance |
|---|
| Transvaginal ultrasound (TVUS) | Endometrioma: homogeneous, ground-glass echogenicity, "chocolate cyst." Fails to resolve after 1–2 menstrual cycles. Does NOT diagnose peritoneal disease |
| MRI pelvis | Better for deep infiltrating endometriosis (DIE), bowel, bladder, ureteral involvement |
| CA-125 | May be elevated but is non-specific and non-sensitive — not diagnostic. Useful for monitoring, not screening |
| Endometrial biopsy | Investigational — nerve fibre detection; not yet routine standard of care |
| Laparoscopy | GOLD STANDARD — definitive diagnosis by direct visualisation ± histological biopsy |
Laparoscopic Findings
| Lesion Type | Appearance | Significance |
|---|
| Early/active lesions | Red/flame lesions, clear vesicles, petechiae | High prostaglandin production → severe pain even in mild disease |
| Established lesions | Powder-burn (black/dark brown) lesions | More longstanding |
| Fibrotic lesions | White fibrotic plaques, adhesions | Late disease |
| Endometrioma | "Chocolate cyst" — dark brown fluid inside ovarian cyst | |
| Deep infiltrating | Nodules at uterosacral ligaments, rectovaginal septum, bowel wall | Strongly associated with pain and dyschezia |
Positive histology confirms the diagnosis; negative histology does NOT exclude it.
ASRM Staging (rAFS Classification)
| Stage | Score | Description |
|---|
| I — Minimal | 1–5 | Isolated superficial implants |
| II — Mild | 6–15 | More implants, small adhesions |
| III — Moderate | 16–40 | Multiple implants + endometrioma + peritubal/periovarian adhesions |
| IV — Severe | >40 | Large endometriomas + dense adhesions, DIE |
⚠️ Important: Stage does NOT correlate with pain severity. A stage I patient can have debilitating pain; stage IV may be pain-free. Stage does correlate with fertility impact.
STATION 4 — MANAGEMENT
Principles of Treatment
Treatment is guided by:
- The primary complaint — pain vs. infertility vs. both
- Desire for future fertility
- Severity and location of disease
- Age and previous treatments
A. Medical Management (Pain-focused)
First-line (not trying to conceive)
- NSAIDs (e.g., ibuprofen, mefenamic acid) — symptom relief; do not treat lesions
- Combined oral contraceptive pill (COCP) — continuous regimen preferred over cyclic; reduces dysmenorrhea; lighter, shorter periods
- Cyclic and continuous OCP equally effective; continuous may better maintain remission after surgery
Second-line
- High-dose progestins — medroxyprogesterone acetate, norethindrone acetate; as effective as GnRH analogues; effective in ~75% of women
- Levonorgestrel IUS (Mirena) — as effective as GnRH depot for chronic pain; good long-term option
- Etonogestrel implant — as effective as DMPA
Third-line / Specialist
-
GnRH agonists (e.g., leuprorelin, goserelin) + add-back therapy:
- Create pseudo-menopause; reduce lesion size and pain
- Side effects: hot flushes, bone loss, vaginal dryness, mood changes
- Add-back: norethindrone acetate 2.5–5 mg/day ± low-dose oestrogen to reduce side effects
- Typically limited to 6–12 months (bone protection); can extend with add-back + bisphosphonate
- Recurrence after stopping: 36–70% at 5 years
-
GnRH antagonists (e.g., elagolix, relugolix) — newer; oral; rapid onset; dose-dependent oestrogen suppression
-
Danazol — androgenic; inhibits LH surge and steroidogenesis; anti-inflammatory; significant androgenic side effects (acne, hirsutism, voice changes, weight gain) → less commonly used
-
Aromatase inhibitors (e.g., letrozole, anastrozole) — block peripheral oestrogen synthesis; used in refractory cases; always combined with ovarian suppression in premenopausal women
B. Surgical Management
For Pain
- Laparoscopic ablation or excision of endometriotic lesions + adhesiolysis
- More effective than diagnostic laparoscopy alone
- Excision preferred over ablation (lower recurrence rates)
- Endometrioma: laparoscopic cystectomy preferred over drainage + ablation
- Cystectomy: lower recurrence of pain, lower endometrioma recurrence, better spontaneous pregnancy rates
- Drain + ablation: reserved for large cysts where excision risks removing significant ovarian tissue
- Deep infiltrating endometriosis: complete surgical excision in a single-step procedure at a specialist centre (multidisciplinary)
- Hysterectomy ± bilateral salpingo-oophorectomy (BSO): for women who have completed childbearing with severe, refractory disease; most definitive treatment
For Infertility
- Surgical excision of minimal/mild endometriosis improves fecundity (more effective than diagnostic laparoscopy alone)
- Suppression of ovulation is NOT effective for improving fertility
- IVF/ART: recommended for moderate-severe disease or failed surgical/medical treatment
C. Multidisciplinary / Adjunct
- Pelvic floor physiotherapy
- Pain psychology / CBT (especially for central sensitisation / endometriosis-related pain syndrome)
- Treat co-morbidities: IBS, IC/PBS, vulvodynia, anxiety concurrently
- Dietitian (low-FODMAP for bowel symptoms)
STATION 5 — DIFFERENTIAL DIAGNOSIS
Main Differentials for Endometriosis (by Symptom)
For Dysmenorrhea + Pelvic Pain
| Condition | Distinguishing Features |
|---|
| Primary dysmenorrhea | Starts at menarche; no fixed uterus; normal examination; responds well to NSAIDs/OCP |
| Adenomyosis | Uterus globularly enlarged and tender; dysmenorrhea + menorrhagia; confirmed on MRI/TVUS |
| Pelvic Inflammatory Disease (PID) | Acute/subacute; cervical excitation; purulent discharge; fever; elevated CRP/WBC; Chlamydia/gonorrhoea history |
| Ovarian cyst | May be asymptomatic; ultrasound-diagnosable; not cyclically related |
| Ovarian torsion | Acute severe unilateral pain; nausea/vomiting; Doppler shows absent/reduced flow |
| Uterine fibroids | Uterus enlarged/irregular; menorrhagia; urinary frequency; no cyclicity with dyschezia |
| Ectopic pregnancy | Acute unilateral pain; positive βhCG; no intrauterine pregnancy on TVUS; haemodynamic instability in rupture |
For Deep Dyspareunia
- Adenomyosis, PID (chronic), ovarian cyst, pelvic adhesions (any cause), vaginal pathology
For Dyschezia / Bowel Symptoms
| Condition | Distinguishing Features |
|---|
| IBS (Irritable Bowel Syndrome) | Not cyclically related; bloating, altered bowel habit; no haematochezia; Rome IV criteria |
| IBD (Crohn's / UC) | Persistent, not cyclic; haematochezia; weight loss; elevated CRP/ESR; colonoscopy confirms |
| Diverticulitis | Older patients; LIF pain; fever; CT confirms |
For Infertility
- Tubal factor (post-PID), PCOS, male factor, hypothalamic amenorrhoea, uterine anomaly
For Adnexal Mass (Endometrioma vs.)
| Condition | Key Feature |
|---|
| Haemorrhagic corpus luteum | Resolves in 1–2 cycles; low-level internal echoes |
| Ovarian teratoma (dermoid) | Hyperechoic component, calcification on TVUS |
| Ovarian malignancy | Post-menopausal; solid components; elevated CA-125; colour Doppler low-resistance flow |
| Tubo-ovarian abscess | Fever; purulent discharge; PID history |
Quick-Reference Summary Table
| Feature | Endometriosis |
|---|
| Prevalence | ~10% reproductive-age women; up to 50% with unexplained infertility |
| Hallmark triad | Dysmenorrhea + Dyspareunia + Dyschezia |
| Gold standard diagnosis | Laparoscopy with histological confirmation |
| Staging | rASRM Stage I–IV (does NOT correlate with pain severity) |
| 1st-line medical Rx | NSAIDs + COCP (continuous) |
| 2nd-line | Progestins, LNG-IUS |
| 3rd-line | GnRH agonist + add-back; GnRH antagonists; Danazol; Aromatase inhibitors |
| Surgical Rx for pain | Laparoscopic excision > ablation; cystectomy for endometrioma |
| Surgical Rx for infertility | Laparoscopic excision (minimal/mild); IVF for moderate/severe |
| Ovarian suppression for fertility? | ❌ NOT effective |
| Definitive Rx | Hysterectomy + BSO (if childbearing complete) |
| Recurrence | Common; lifelong condition requiring long-term management |
Sources: Berek & Novak's Gynecology, Chapter 13 (Endometriosis); Robbins & Kumar Basic Pathology; Swanson's Family Medicine Review — all cross-referenced with 2024–2026 ESHRE/ACOG guidelines (PMID 38815122, 41712950).
Good luck on your OSCE! The examiners will particularly value you linking cyclic symptoms to disease mechanism, recognising that stage ≠ pain severity, and articulating the fertility management pathway clearly.Here's what this guide covers for each of your 5 stations:
Station 1 – History Taking: Structured approach with the full symptom complex (dysmenorrhea, dyspareunia, dyschezia, infertility, urinary symptoms), gynaecological/obstetric/family history, and red flags. The examiner's key look-out — identifying the cyclic nature of symptoms and the endometriosis triad.
Station 2 – Patient Education: Plain-language explanations of what endometriosis is, what it means for fertility, why it takes so long to diagnose, what treatment options exist, and the chronic/relapsing nature of the disease.
Station 3 – Diagnosis: Non-surgical clinical diagnosis, examination findings, investigations (TVUS, MRI, CA-125), laparoscopic appearances of different lesion types, and the rASRM staging system with its critical caveat — stage does NOT predict pain.
Station 4 – Management: Full pharmacological ladder (NSAIDs → COCP → progestins → GnRH agonists + add-back → aromatase inhibitors/danazol), surgical options (excision > ablation; cystectomy > drainage; hysterectomy for end-stage), and fertility-specific pathways including IVF. Multidisciplinary care for central sensitisation.
Station 5 – Differential Diagnosis: Organised by presenting symptom (pelvic pain, dyschezia, adnexal mass, infertility) covering all high-yield differentials with distinguishing features.